NEO-301

N/A

Report date: 2025/12/22 10:41:39

Base Information

Drug NameNEO-301
Drug Alias Name31.1CNEO-301
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-GPA33
TargetsCell surface A33 antigen
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeogenix Oncology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrecision Biologics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A